| abstract |
New methods are provided for treating and / or reducing the likelihood of acquired symptoms or diseases selected from urinary incontinence, vaginal atrophy, atrophic vaginitis, vaginal dryness, dyspareunia and sexual dysfunction in postmenopausal women, including intravaginal administration of an effective amount of a sex steroid hormone precursor selected from the group consisting of dehydroepiandrosterone, dehydroepiantrosterone sulfate, androst-5-en-3β, 17β-diol and 4-androsten-3,17-dione at a dose of 0.5-13 mg / day. In addition, intravaginal compositions and vaginal suppositories useful in the methods of the invention are provided. |